Snoddy A M, Tessel R E
Pharmacol Biochem Behav. 1983 Aug;19(2):205-10. doi: 10.1016/0091-3057(83)90040-0.
The interaction of amphetamine with noradrenergic neurons could mediate a portion of the drug's discriminative stimulus properties. To test this hypothesis, mice were trained to discriminate 1.0 or 3.2 mg/kg amphetamine, 32 mg/kg of the selective norepinephrine uptake inhibitor, nisoxetine, or 32 mg/kg nisoxetine + 1.0 mg/kg amphetamine from saline. Differential drug- or saline-appropriate responding was determined using a two photocell-beam procedure with beam interruption as the operant. Reinforcement (5-sec access to evaporated milk) was presented on a fixed-ratio 20 (FR-20) schedule. Mice trained to discriminate 1.0 mg/kg amphetamine from saline generalized to nisoxetine (32 mg/kg) alone and to doses of 0.56 mg/kg amphetamine and above but not to lower doses unless pretreated with nisoxetine (20 or 32 mg/kg). Mice trained to discriminate nisoxetine (32 mg/kg) from saline generalized to 0.56, 1.0 and 3.2 mg/kg amphetamine and generalized to all amphetamine doses when pretreated with nisoxetine (32 mg/kg). Mice trained to discriminate the drug combination from saline generalized to nisoxetine (32 mg/kg) alone, and to 3.2 mg/kg amphetamine tested alone, to 0.56 mg/kg of amphetamine or above when the lower dose of nisoxetine (20 mg/kg) was used, and to all test doses of amphetamine with nisoxetine (32 mg/kg) pretreatment. Mice trained to discriminate 3.2 mg/kg amphetamine from saline generalized to no test dose of amphetamine following either saline or nisoxetine (32 mg/kg) pretreatment. Testing with several doses of pentobarbital (1.0, 3.0, 10.0 and 18.0 mg/kg) resulted in saline-appropriate responding regardless of training group.(ABSTRACT TRUNCATED AT 250 WORDS)
苯丙胺与去甲肾上腺素能神经元的相互作用可能介导了该药物部分辨别刺激特性。为验证这一假设,对小鼠进行训练,使其能够区分1.0或3.2毫克/千克的苯丙胺、32毫克/千克的选择性去甲肾上腺素摄取抑制剂尼索西汀,或32毫克/千克尼索西汀 + 1.0毫克/千克苯丙胺与生理盐水。采用双光电管光束程序,以光束中断作为操作行为,确定药物或生理盐水给药后的不同反应。强化(5秒获取蒸发乳)按固定比率20(FR - 20)时间表呈现。经训练能区分1.0毫克/千克苯丙胺与生理盐水的小鼠,单独对尼索西汀(32毫克/千克)以及0.56毫克/千克及以上剂量的苯丙胺产生泛化反应,但对更低剂量则无反应,除非预先给予尼索西汀(20或32毫克/千克)。经训练能区分尼索西汀(32毫克/千克)与生理盐水的小鼠,对0.56、1.0和3.2毫克/千克苯丙胺产生泛化反应,且在预先给予尼索西汀(32毫克/千克)时,对所有苯丙胺剂量均产生泛化反应。经训练能区分药物组合与生理盐水的小鼠,单独对尼索西汀(32毫克/千克)、单独测试的3.2毫克/千克苯丙胺、使用较低剂量尼索西汀(20毫克/千克)时对0.56毫克/千克及以上剂量的苯丙胺,以及在预先给予尼索西汀(32毫克/千克)时对所有测试剂量的苯丙胺与尼索西汀组合产生泛化反应。经训练能区分3.2毫克/千克苯丙胺与生理盐水的小鼠,在给予生理盐水或尼索西汀(32毫克/千克)预处理后,对任何测试剂量的苯丙胺均无泛化反应。用几种剂量的戊巴比妥(1.0、3.0、10.0和18.0毫克/千克)进行测试,无论训练组如何,均产生与生理盐水给药后一致的反应。(摘要截选至250字)